$64 Billion Market Predicted by 2016 for Pharma Contract Manufacturing

Global revenues for contract pharma manufacturing will exceed $64 billion in 2016, according to London-based business analysis company visiongain. Driving that growth will be production of finished dosage forms, the company’s report, Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021, states.
International Pharmaceutical Regulatory Monitor